PUTRAJAYA The 393rd Drug Control Authority meeting on Friday (Feb 8) approved the registration of Zolgensma, a cell and gene therapy product, for the first time since the product's control came into force on Jan 1, 2021.
President director of state-run insurer BPJS Health, Ghufron Mukti, said that his party will not cover the cost of the trivalent dengue vaccine (TDV), or the .
BRAZIL: Prefix of Pharmaceutical Substances Is Common Use - International Trademark Association inta.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inta.org Daily Mail and Mail on Sunday newspapers.